Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Thermo Fisher acquires Clario for $8.875 billion

PUBLIC · TMOMar 24, 2026•6 months ago

Acquiring Company

Thermo Fisher Scientific

Acquired Company

Clario

WalthamPhiladelphiaBiotechnologySoftwareHealth CareScience And Engineeringresearchresearch

Description

Thermo Fisher Scientific Inc. has completed its acquisition of Clario Holdings, Inc. for $8.875 billion in cash. This acquisition aims to enhance Thermo Fisher's offerings in clinical research and improve drug development processes. Clario's capabilities are expected to contribute significantly to Thermo Fisher's financial performance and operational synergies.

Company Information

Company

Thermo Fisher Scientific

Location

168 3rd Ave

Waltham, Massachusetts, United States

About

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Don't miss Thermo Fisher Scientific's next move

Get an email the moment Thermo Fisher Scientific makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Dominic
Senior decision-maker at this company
••••••••@••••••••

See Dominic's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Thermo Fisher Scientific's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Clario?

Clario was acquired by Thermo Fisher Scientific, based in Waltham. The deal was reported on March 24, 2026. Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Thermo Fisher Scientific is publicly traded (TMO) and operates in Biotechnology.

When did Thermo Fisher Scientific acquire Clario?

Thermo Fisher Scientific's acquisition of Clario was reported on March 24, 2026. Thermo Fisher Scientific Inc. has completed its acquisition of Clario Holdings, Inc. for $8.875 billion in cash. This acquisition aims to enhance Thermo Fisher's offerings in clinical research and improve drug development processes. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Clario do?

Clario Group is a new global strategic communications and advisory consultancy. It aims to help organizations adapt, grow, and lead in a disruptive era. It is privately held, operating in research, and is based in Philadelphia.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.